ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,967Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 944

$707K Total Retail Price of All Prescriptions

Rank: 66 out of 944

483 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,810 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
AMLODIPINE BESYLATE 521 438 1 5
SIMVASTATIN 515 427 2 1
OMEPRAZOLE 424 309 3 4
FENOFIBRATE 410 331 4 58
LOSARTAN POTASSIUM 360 289 5 16
PRAVASTATIN SODIUM 356 269 6 17
HYDROCODONE-ACETAMINOPHEN 344 186 S3 7 10
POTASSIUM CHLORIDE 342 246 8 15
NIASPAN 284 233 9 76
LISINOPRIL 276 217 10 3
LEVOTHYROXINE SODIUM 264 225 11 2
SPIRONOLACTONE 202 161 12 44
CRESTOR 199 151 13 28
ALLOPURINOL 195 161 14 22
ZOLPIDEM TARTRATE 176 103 15 25
DOXAZOSIN MESYLATE 175 123 16 60
FUROSEMIDE 174 117 17 6
ZETIA 169 110 18 59
METFORMIN HCL ER 168 163 19 49
ALENDRONATE SODIUM 164 159 20 20
METOPROLOL TARTRATE 161 125 21 8
METFORMIN HCL 160 93 22 12
ATENOLOL 153 129 23 11
AGGRENOX 140 129 24 186
TRIAMTERENE-HCTZ 130 117 25 33
METOPROLOL SUCCINATE 122 107 26 14
LOSARTAN-HYDROCHLOROTHIAZIDE 116 69 27 54
PROAIR HFA 100 61 28 56
HYDROCHLOROTHIAZIDE 98 93 29 9
ATORVASTATIN CALCIUM 98 81 29 13
MELOXICAM 97 53 31 68
RANITIDINE HCL 94 65 32 42
METHOCARBAMOL 92 33 R 33 252
TRAMADOL HCL 90 38 34 21
DILTIAZEM ER 87 60 35 88
CARVEDILOL 82 77 36 30
DIOVAN 81 63 37 38
FAMOTIDINE 81 52 37 74
CLOPIDOGREL 75 54 39 36
GLIMEPIRIDE 75 58 39 47
ADVAIR DISKUS 69 45 41 31
FLUTICASONE PROPIONATE 67 50 42 40
JANUVIA 67 56 42 81
PANTOPRAZOLE SODIUM 66 45 44 34
GABAPENTIN 66 46 44 18
LOVASTATIN 64 64 46 26
BENICAR 64 64 46 199
TRAZODONE HCL 63 30 48 45
OXYCODONE HCL 61 40 S2 49 50
NEXIUM 60 23 50 53
TAMSULOSIN HCL 59 59 51 27
COMBIVENT 59 39 51 107
CITALOPRAM HBR 59 32 51 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 33 54 29
PLAVIX 55 45 55 55
SPIRIVA 54 41 56 65
CYCLOBENZAPRINE HCL 52 19 R 57 86
WARFARIN SODIUM 51 51 58 7
DOXYCYCLINE HYCLATE 50 38 59 165
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.